JP2011078421A5 - - Google Patents

Download PDF

Info

Publication number
JP2011078421A5
JP2011078421A5 JP2010254743A JP2010254743A JP2011078421A5 JP 2011078421 A5 JP2011078421 A5 JP 2011078421A5 JP 2010254743 A JP2010254743 A JP 2010254743A JP 2010254743 A JP2010254743 A JP 2010254743A JP 2011078421 A5 JP2011078421 A5 JP 2011078421A5
Authority
JP
Japan
Prior art keywords
inclusion body
protein
heterologous protein
proteins
regulate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2010254743A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011078421A (ja
Filing date
Publication date
Priority claimed from SI200200187A external-priority patent/SI21273A/sl
Application filed filed Critical
Publication of JP2011078421A publication Critical patent/JP2011078421A/ja
Publication of JP2011078421A5 publication Critical patent/JP2011078421A5/ja
Withdrawn legal-status Critical Current

Links

JP2010254743A 2002-07-31 2010-11-15 封入体における高い量の正しく折りたたまれた異種タンパク質の生産方法 Withdrawn JP2011078421A (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SI200200187A SI21273A (sl) 2002-07-31 2002-07-31 Priprava inkluzijskih teles z visokim deležem pravilno zvitega prekurzorja heterolognega proteina

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2004526684A Division JP4703186B2 (ja) 2002-07-31 2003-06-11 封入体における高い量の正しく折りたたまれた異種タンパク質の生産方法

Publications (2)

Publication Number Publication Date
JP2011078421A JP2011078421A (ja) 2011-04-21
JP2011078421A5 true JP2011078421A5 (enExample) 2012-02-23

Family

ID=31713326

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2004526684A Expired - Fee Related JP4703186B2 (ja) 2002-07-31 2003-06-11 封入体における高い量の正しく折りたたまれた異種タンパク質の生産方法
JP2010254743A Withdrawn JP2011078421A (ja) 2002-07-31 2010-11-15 封入体における高い量の正しく折りたたまれた異種タンパク質の生産方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2004526684A Expired - Fee Related JP4703186B2 (ja) 2002-07-31 2003-06-11 封入体における高い量の正しく折りたたまれた異種タンパク質の生産方法

Country Status (9)

Country Link
US (1) US20050283000A1 (enExample)
EP (1) EP1527188B1 (enExample)
JP (2) JP4703186B2 (enExample)
AR (1) AR040719A1 (enExample)
AT (1) ATE456665T1 (enExample)
AU (1) AU2003250347A1 (enExample)
DE (1) DE60331149D1 (enExample)
SI (2) SI21273A (enExample)
WO (1) WO2004015124A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI21639A (sl) * 2003-12-23 2005-06-30 LEK farmacevtska dru�ba d.d. Farmacevtski pripravek, ki vsebuje nemicelarne sulfobetaine
EP1939212A1 (en) * 2006-12-20 2008-07-02 LEK Pharmaceuticals D.D. Organic compounds
WO2008096370A2 (en) * 2007-02-05 2008-08-14 Natco Pharma Limited An efficient and novel purification method of recombinant hg-csf
JPWO2008133141A1 (ja) * 2007-04-24 2010-07-22 東洋紡績株式会社 オスモチン組換えタンパク質およびその製造方法、並びにその利用
MX2010002448A (es) 2007-08-27 2010-10-04 Biogenerix Ag Formulacion liquida del g-csf conjugado.
US20090294362A1 (en) * 2008-05-30 2009-12-03 Persson Jonas Par Stationary phase for hydrophilic interaction chromatography
EP2542574B1 (en) 2010-03-04 2017-08-09 Pfenex Inc. Method for producing soluble recombinant interferon protein without denaturing
US8455218B2 (en) 2010-04-01 2013-06-04 Pfenex, Inc. Methods for G-CSF production in a Pseudomonas host cell
JP5836621B2 (ja) 2011-03-31 2015-12-24 株式会社マキタ 動力工具
HUP1200171A1 (hu) * 2012-03-19 2013-09-30 Richter Gedeon Nyrt Módszerek polipeptidek elõállítására
HUP1200172A2 (en) 2012-03-19 2013-10-28 Richter Gedeon Nyrt Methods for refolding g-csf from inclusion bodies
US10183967B2 (en) 2013-02-12 2019-01-22 Bristol-Myers Squibb Company Tangential flow filtration based protein refolding methods
EP3299378B1 (en) 2013-02-12 2019-07-31 Bristol-Myers Squibb Company High ph protein refolding methods
CN105813695A (zh) * 2013-11-01 2016-07-27 斯弗尤姆生物制药有限公司 用于透皮递送治疗剂和美容剂的包含体
CN104152515B (zh) * 2014-08-14 2019-12-31 江苏奥赛康药业有限公司 一种制备重组人粒细胞集落刺激因子的培养基及发酵方法
JP2020080727A (ja) * 2018-11-26 2020-06-04 Ｓｐｉｂｅｒ株式会社 目的タンパク質の製造方法
CN116194460A (zh) * 2020-06-09 2023-05-30 Icosavax股份有限公司 制备病毒样颗粒的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4810643A (en) * 1985-08-23 1989-03-07 Kirin- Amgen Inc. Production of pluripotent granulocyte colony-stimulating factor
JPH0618778B2 (ja) * 1985-10-04 1994-03-16 中外製薬株式会社 白血球減少症治療剤
IE912365A1 (en) * 1990-07-23 1992-01-29 Zeneca Ltd Continuous release pharmaceutical compositions
DE4037196A1 (de) * 1990-11-22 1992-05-27 Boehringer Mannheim Gmbh Verfahren zur reaktivierung von denaturiertem protein
CA2223433C (en) * 1995-06-07 2003-11-18 Amgen Inc. Ob protein compositions and methods
US5912327A (en) * 1996-09-30 1999-06-15 Human Genome Sciences, Inc. Method of purifying chemokines from inclusion bodies
JP3535525B2 (ja) * 1996-12-27 2004-06-07 日本たばこ産業株式会社 花器特異的遺伝子およびそのプロモーター配列
US20020052026A1 (en) * 1997-10-08 2002-05-02 Steven M. Vicik Methods of refolding proteins
US6677139B1 (en) * 1999-12-23 2004-01-13 Genecor International, Inc. Methods for production of proteins in host cells
WO2003102013A2 (en) * 2001-02-23 2003-12-11 Gonzalez-Villasenor Lucia Iren Methods and compositions for production of recombinant peptides
SI21102A (sl) * 2001-12-19 2003-06-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Postopek za izolacijo biološko aktivnega granulocitne kolonije stimulirajočega dejavnika

Similar Documents

Publication Publication Date Title
JP2011078421A5 (enExample)
IL281648A (en) Solid forms of }[5-(3-chlorophenyl)-3-hydroxypyridi-2-carbonyl]amino{ acetic acid, their compositions and uses
PL2493325T3 (pl) Wyrób zawierający białka serwatkowe i sposób jego wytwarzania
ZA201201791B (en) Method for the preparation of 2,5-furandicarboxylic acid and esters thereof
WO2012163869A3 (en) Composition comprising an alkoxysilane and a modified starch, and cosmetic use thereof
EP2670375A1 (en) Dental composition, method of producing and use thereof
JP2009256391A5 (enExample)
JP2011037901A5 (enExample)
PL2569483T3 (pl) Sposób wytwarzania kompozycji zawierającej fibrylowaną celulozę oraz kompozycja
PL2352386T3 (pl) Sposób wytwarzania związku kwasu n-masłowego w postaci mikrokapsułkowanej do spożycia przez zwierzęta lub ludzi
PT2723453T (pt) Métodos para a produção de uma composição cosmética a partir de fluido de eclosão de ovos de salmonidae e suas utilizações para melhorar a aparência cosmética da pele
JP2012098988A5 (enExample)
ZA201202387B (en) Particulate composition containing anhtdrous crystalline of 2-o-a-d-glucosyl-l-ascorbic acid,process for producing the same, and uses thereof
UA105487C2 (uk) Заміщені дигідропіразолони як інгібітори hif-проліл-4-гідроксилази
EA201491112A1 (ru) Перколированный муллит и способ его получения
WO2012010978A3 (en) A method of treating alzheimer's disease
WO2009080838A3 (en) Gum confections
CA2899024C (en) Crystalline forms of {[1-cyano-5-(4-chlorophenoxy)-4-hydroxy-isoquinoline-3-carbonyl]-amino}-acetic acid
WO2012175742A3 (en) Methods for the production of a cosmetic composition comprising leukolectin and uses thereof
EP2732028A4 (en) COMPOSITIONS AND METHODS OF PREPARING ISOPRENE
EP2609815A4 (en) PROCESS FOR PRODUCTION OF FISH PASTE PRODUCT, AND ENZYMA PREPARATION FOR MODIFICATION OF FISH PASTE PRODUCT
HUE040484T2 (hu) Eljárás (3S,3S')4,4'-diszulfándiilbisz(3-aminobután-1-szulfonsav) elõállítására
WO2015018507A3 (en) A novel process for the preparation of febuxostat
JP2008280345A5 (enExample)
WO2011139752A3 (en) Preparation of polypeptides and salts thereof